Research Comparison
CJC-1295 / Ipamorelin vs Sermorelin
CJC-1295 / Ipamorelin and Sermorelin are often compared because both sit in growth-hormone axis research. CJC-1295 / Ipamorelin acts on GHRH analog + ghrelin secretagogue and is studied for endogenous GH-pulse research, while Sermorelin acts on GHRH receptor (GHRHR) and is studied for pituitary GH-secretion research. Both are supplied as lyophilized powder for in-vitro laboratory research only — this page compares mechanism and research status, not dosing or human use.
CJC-1295 / Ipamorelin
Growth-hormone axis
Sermorelin
Growth-hormone axis
Frequently asked
- What is the difference between CJC-1295 / Ipamorelin and Sermorelin?
- The main difference is mechanism and research stage. CJC-1295 / Ipamorelin targets GHRH analog + ghrelin secretagogue (preclinical / research) and is studied for endogenous GH-pulse research; Sermorelin targets GHRH receptor (GHRHR) (research-use-only (former geref diagnostic)) and is studied for pituitary GH-secretion research. Both are research-use-only compounds, not for human or animal use.
- Are CJC-1295 / Ipamorelin and Sermorelin approved for human use?
- No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — CJC-1295 / Ipamorelin: preclinical / research; Sermorelin: research-use-only (former geref diagnostic) — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.
- How is purity verified for CJC-1295 / Ipamorelin and Sermorelin?
- Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.
Related comparisons
Build a multi-compound set in the Stack Builder or run the reconstitution calculator.
Research references
Primary literature for CJC-1295 / Ipamorelin and Sermorelin. Provided for scientific context only — not medical or dosing guidance.
- Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID 16352683 →
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID 9849822 →
Research use only. This comparison covers mechanism, target, and research status. It is not medical, therapeutic, or dosing advice. Compounds sold by Renova Wellness™ are for in-vitro laboratory research and are not for human or animal consumption.